Sponsor:
UI Contact:
Updated Date:
The National Institutes of Health, through its NIH Guide, has recently published the following funding-related policy notices, general notices, notices of changes, notices of special interest NOSI, and funding opportunities:
Policy Notices
- Special Exception to the NIH/AHRQ/NIOSH Post-Submission Material Policy During the COVID-19 Pandemic
National Institutes of Health
General Notices
- Pre-Application Webinar for NCI's Serological Sciences Network Funding Opportunities (RFA-CA-20-038, RFA-CA-20-039)
National Cancer Institute
National Institute of Allergy and Infectious Diseases
- Notice of Clarification to PAR-19-064, "Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional)"
National Institute on Drug Abuse
- Notice of Pre-Application Webinar and Frequently Asked Questions (FAQs) for PAR-20-220 " Institutional Network Award for Promoting Kidney, Urologic, and Hematologic Research Training (U2C/TL1 - Clinical Trial Not Allowed) "
National Institute of Diabetes and Digestive and Kidney Diseases
- Notice of Joint DMS/NIGMS Initiative to Support Research at the Interface of the Biological and Mathematical Sciences
National Institute of General Medical Sciences
- Notice of Availability of National Childrens Study (NCS) Vanguard Biological and Environmental Sample Materials
Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Notice of Participation of National Institute of Nursing Research (NINR) in PA-20-135 "Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional")
National Institute of Nursing Research
- Guide Notice of Information Highlighting Harmonization and Data Sharing Expectations for Supplement and Revision Projects Addressing Social, Behavioral, Economic and Health Impacts of the COVID-19 Public Health Emergency
National Institutes of Health
- Guidance Regarding Change in Status, Including Absence of PD/PI and Other Key Personnel Named in the Notice of Award
National Institutes of Health
- Notice of Pre-Application Webinars for the High-Risk, High-Reward Research Program's Pioneer, New Innovator, Transformative Research, and Early Independence Awards
Office of Strategic Coordination (Common Fund)
- Request for Information: Soliciting Input on the NIGMS 2021-2025 Strategic Plan Framework
National Institute of General Medical Sciences
Notice of Changes to Funding Opportunities
- Notice of NLM's Participation in PA-20-135 "Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)"
National Library of Medicine
- Notice of NIMH Participation in PA-20-135, "Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)"
National Institute of Mental Health
- Notice of Extension of the Response Date for NOT-NS-20-026 "Request for Information: Soliciting Input on Areas of Health Disparities and Inequities in Neurological Disease and/or Care in the United States Across the Lifespan"
National Institute of Neurological Disorders and Stroke
- Notice of Change in Application Due Date for NOT-OD-20-107 "Notice of Special Interest (NOSI): Administrative Supplements to Existing NIH ECHO Cooperative Agreements (Admin Supp - Clinical Trial Not Allowed) for COVID-19 related Research"
National Institutes of Health
Notices of Intent to Publish
- Notice of Intent to Publish a Funding Opportunity Announcement for INIA Research Project (U01 Clinical Trial Optional)
National Institute on Alcohol Abuse and Alcoholism
Notices of Special Interest
- Notice of Special Interest (NOSI): NIAID Priorities for Biomedical Knowledgebases & Repositories
National Institute of Allergy and Infectious Diseases
- Notice of Special Interest (NOSI): Role of Astrocytes and Astrocytic Networks in Drug Abuse
National Institute on Drug Abuse
- Notice of Special Interest (NOSI): Bold New Bioengineering Research for Heart, Lung, Blood and Sleep Disorders and Diseases (Reissue)
National Heart, Lung, and Blood Institute
- Notice of Special Interest (NOSI): Emergency Competitive Revisions for Social, Ethical, and Behavioral Implications (SEBI) Research on COVID-19 Testing among Underserved and/or Vulnerable Populations
National Institutes of Health
John E. Fogarty International Center
National Center for Advancing Translational Sciences
National Center for Complementary and Integrative Health
National Cancer Institute
National Eye Institute
National Human Genome Research Institute
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Environmental Health Sciences
National Institute of General Medical Sciences
National Institute of Mental Health
National Institute on Minority Health and Health Disparities
National Institute of Neurological Disorders and Stroke
National Institute of Nursing Research
National Library of Medicine
Office of Behavioral and Social Sciences Research
Office of Disease Prevention
Office of Research on Women's Health
- Notice of Special Interest (NOSI): Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations
National Institutes of Health
John E. Fogarty International Center
National Center for Advancing Translational Sciences
National Center for Complementary and Integrative Health
National Cancer Institute
National Eye Institute
National Human Genome Research Institute
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Environmental Health Sciences
National Institute of General Medical Sciences
National Institute of Mental Health
National Institute on Minority Health and Health Disparities
National Institute of Neurological Disorders and Stroke
National Institute of Nursing Research
National Library of Medicine
Office of Behavioral and Social Sciences Research
Office of Disease Prevention
Office of Research on Women's Health
- Notice of Special Interest (NOSI): Limited Competition for Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations
National Institutes of Health
National Center for Advancing Translational Sciences
National Center for Complementary and Integrative Health
National Cancer Institute
National Eye Institute
National Human Genome Research Institute
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Environmental Health Sciences
National Institute of General Medical Sciences
National Institute of Mental Health
National Institute on Minority Health and Health Disparities
National Institute of Neurological Disorders and Stroke
National Institute of Nursing Research
National Library of Medicine
Office of Behavioral and Social Sciences Research
Office of Disease Prevention
Office of Research on Women's Health
Funding Opportunities
- Administrative Supplement for Research on Dietary Supplements (Admin Supp-Clinical Trial Not Allowed)
Office of Dietary Supplements
John E. Fogarty International Center
National Center for Complementary and Integrative Health
National Cancer Institute
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Environmental Health Sciences
National Institute on Minority Health and Health Disparities
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs. - Pilot Projects Increasing the Impact of the NIH Centers for Advancing Research on Botanicals and Other Natural Products (PI2 CARBON) (R03 Clinical Trials Not Allowed)
Office of Dietary Supplements
National Center for Complementary and Integrative Health
- Global Infectious Disease Research Training Program (D43 Clinical Trial Optional)
John E. Fogarty International Center
National Institute of Allergy and Infectious Diseases
- Center for Inherited Disease Research (CIDR) High Throughput Sequencing and Genotyping Resource Access (X01)
National Human Genome Research Institute. - Improving Smoking Cessation Interventions among People Living with HIV (R01 Clinical Trial Optional)
National Cancer Institute
National Institute on Drug Abuse
National Institute on Minority Health and Health Disparities
- Improving Smoking Cessation Interventions among People Living with HIV (R21 Clinical Trial Optional)
National Cancer Institute
National Institute on Drug Abuse
Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at dsp@uiowa.edu or 335-2123, or email Carrie Damon at carolyn-damon@uiowa.edu or Dave Myers at dave-myers@uiowa.edu or Lynn Hudachek at lynn-hudachek @uiowa.edu